Category: Investor updates

The following response to “Appendix 3Y — Change of Director’s Interest Notice Query” has been announced. Read the response.

Imagion Biosystems has released “Notice Pursuant to Section 708A(5)(e) of the Corporations Act.” Read the notice.

Imagion Biosystems has released Appendix 3B: New issue announcement, application for quotation of additional securities and agreement. Read Appendix 3B.

Imagion Biosystems has released Change of Director’s Interest Notices for David Ludvigson, Mark Van Asten, and Robert Proulx. Read the Change in Director’s Interest Notices:

Imagion Biosystems Limited has released “Form 604: Notice of change of interests of substantial holder” to the market. Read Form 604.

Imagion Biosystems Limited has announced “Form 605: Notice of ceasing to be a substantial holder.” Read Form 605.

Imagion Biosystems has announced the successful completion of the renounceable rights issue raising approximately $3.6 million. Read Imagion Biosystems’ Right Issue raises $3.6 million.

Imagion Biosystems Limited (ASX: IBX) (the Company) refers to its renounceable pro rata right issue offer of new fully paid ordinary shares (New Shares) announced